# OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women

> **NCT02744131** · NA · UNKNOWN · sponsor: **Kar Clinic & Hospital Pvt. Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Oral contraceptive pill combination of ethyl estradiol and Cyproterone acetate
- **DRUG:** Metformin 1500mgs per day

## Key facts

- **NCT ID:** NCT02744131
- **Lead sponsor:** Kar Clinic & Hospital Pvt. Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-09
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744131, "OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02744131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*